PACIFIC ETHANOL, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementCommon Stock • August 13th, 2020 • Pacific Ethanol, Inc. • Industrial organic chemicals • New York
Contract Type FiledAugust 13th, 2020 Company Industry JurisdictionPacific Ethanol, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (“HCW”) as follows:
PACIFIC ETHANOL, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementCommon Stock • September 19th, 2019 • Pacific Ethanol, Inc. • Industrial organic chemicals • New York
Contract Type FiledSeptember 19th, 2019 Company Industry JurisdictionPacific Ethanol, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (“HCW”) as follows:
INNOVATE BIOPHARMACEUTICALS, INC. COMMON STOCK SALES AGREEMENTCommon Stock • October 29th, 2018 • Innovate Biopharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 29th, 2018 Company Industry JurisdictionInnovate Biopharmaceuticals, Inc., a Delaware corporation (the "Company"), confirms its agreement (this "Agreement") with H.C. Wainwright & Co., LLC ("HCW") and Ladenburg Thalmann & Co. Inc. ("Ladenburg", each of HCW and Ladenburg individually an "Agent" and collectively, the "Agents"), as follows:
OCULUS INNOVATIVE SCIENCES, INC. Common Stock (par value $0.0001 per share) At- the-Market Issuance Sales AgreementCommon Stock • April 2nd, 2014 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 2nd, 2014 Company Industry JurisdictionOculus Innovative Sciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows: